###begin article-title 0
###xml 152 153 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN1">*</xref>
###xml 153 153 149 149 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 153 153 149 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
###xml 153 153 149 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref>
alpha2,6-Sialic Acid on Platelet Endothelial Cell Adhesion Molecule (PECAM) Regulates Its Homophilic Interactions and Downstream Antiapoptotic Signaling*
###end article-title 0
###begin p 1
Antiangiogenesis therapies are now part of the standard repertoire of cancer therapies, but the mechanisms for the proliferation and survival of endothelial cells are not fully understood. Although endothelial cells are covered with a glycocalyx, little is known about how endothelial glycosylation regulates endothelial functions. Here, we show that alpha2,6-sialic acid is necessary for the cell-surface residency of platelet endothelial cell adhesion molecule (PECAM), a member of the immunoglobulin superfamily that plays multiple roles in cell adhesion, mechanical stress sensing, antiapoptosis, and angiogenesis. As a possible underlying mechanism, we found that the homophilic interactions of PECAM in endothelial cells were dependent on alpha2,6-sialic acid. We also found that the absence of alpha2,6-sialic acid down-regulated the tyrosine phosphorylation of PECAM and recruitment of Src homology 2 domain-containing protein-tyrosine phosphatase 2 and rendered the cells more prone to mitochondrion-dependent apoptosis, as evaluated using PECAM- deficient endothelial cells. The present findings open up a new possibility that modulation of glycosylation could be one of the promising strategies for regulating angiogenesis.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 617 618 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN3"><sup>2</sup></xref>
###xml 848 849 848 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1056 1057 1056 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1401 1402 1401 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1515 1516 1515 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1516 1517 1516 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9 B10 B11">&#8211;</xref>
###xml 1517 1519 1517 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1562 1564 1562 1564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Angiogenesis is a physiological process that encompasses the growth of capillary blood vessels, and the disturbance of angiogenesis contributes to the pathogenesis of numerous disorders, including cancer (1). Indeed, different types of antiangiogenic agents targeting endothelial cells have been developed as anticancer treatments (2). Pathological angiogenesis is predominantly driven by vascular endothelial growth factor, a proangiogenic growth factor expressed by many solid tumors (3, 4). Angiogenesis is also regulated by endothelial cell adhesion molecules, such as vascular endothelial cadherin (VE-cadherin),2 integrins, and platelet endothelial cell adhesion molecule (PECAM). For integrin activation, a mechanosensory complex composed of PECAM, VE-cadherin, and vascular endothelial growth factor receptor 2 causes the initial response (5). PECAM was originally identified as a major endothelial cell adhesion molecule, but it has recently been recognized to play important roles in controlling the activation and survival of endothelial cells (6). PECAM is considered to be an inhibitory receptor, and its cytoplasmic region possesses an immunoreceptor tyrosine-based inhibitory motif that becomes tyrosine-phosphorylated and subsequently recruits and activates Src homology 2 domain-containing protein-tyrosine phosphatase 2 (SHP2) for the transduction of inhibitory signals to the cell (7). Notably, recent studies have shown that PECAM functions as an inhibitor of mitochondrion-dependent apoptosis (8-12) and regulates pathological angiogenesis (13).
###end p 3
###begin p 4
###xml 396 398 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 479 481 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
Even though most endothelial cell adhesion molecules, including PECAM, are heavily glycosylated, the aspect of how endothelial glycans play roles in vascular physiology and pathology remains largely unknown. The previous observations that vascular endothelial cells express glycoproteins significantly modified with alpha2,6-linked sialic acid by the beta-galactoside sialyltransferase ST6Gal I (14) and that cytokine treatments enhance ST6Gal I expression in endothelial cells (15) prompted us to study the functional roles of alpha2,6-linked sialic acid in normal and pathogenic angiogenesis. In this study using ST6Gal I-deficient mice, we demonstrate that in the absence of alpha2,6-sialic acid, PECAM was unable to remain on the cell surface and incompletely transduced inhibitory signals such as those required for its antiapoptotic role.
###end p 4
###begin title 5
EXPERIMENTAL PROCEDURES
###end title 5
###begin title 6

###end title 6
###begin title 7

###end title 7
###begin title 8
Materials
###end title 8
###begin p 9
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
The sources of the materials used in this study were as follows: tissue culture media and reagents, including Dulbecco's modified Eagle's medium/F-12, from Invitrogen; FuGENE 6 and recombinant N-glycosidase F from Roche Applied Science; protein A-Sepharose Fast Flow from GE Healthcare; protein molecular weight standards from Bio-Rad; and all other chemicals from Sigma or Wako Chemicals. Protein concentrations were determined with BCA protein assay reagents (Pierce). For detection of proteins after SDS-PAGE, 2D-Silver Stain-II (Cosmo Bio) was used. All animal experiments were performed in compliance with the Institutional Guidelines for Animal Experiments of RIKEN.
###end p 9
###begin title 10
Expression Plasmids
###end title 10
###begin p 11
###xml 205 209 205 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R90A</sub>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 395 398 <span type="species:ncbi:10116">rat</span>
###xml 485 488 <span type="species:ncbi:10116">rat</span>
###xml 704 707 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Fc-tagged PECAM (Fc-PECAM) was generated by inserting mouse PECAM amino acids 1-590 into the EcoRV and SpeI sites of pEF encoding the hinge and constant region (Fc) of human IgG1 in-frame. Fc-tagged mPECAMR90A was generated using a QuikChange site-directed mutagenesis kit (Stratagene). A ViraPower adenoviral expression system (Invitrogen) was used to produce recombinant adenoviruses carrying rat ST6Gal I or control LacZ according to the manufacturer's protocol. To achieve this, a rat ST6Gal I-FLAG pcDNA was subcloned into the pENTR TOPO vector (Invitrogen). The ST6Gal I entry clone vector was used in LR clonase recombination reactions (Invitrogen) with the Gateway adenoviral backbone vector pAd/CMV/V5-DEST (Invitrogen).
###end p 11
###begin title 12
Cell Culture
###end title 12
###begin p 13
###xml 128 130 128 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 230 232 230 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 108 114 <span type="species:ncbi:9913">bovine</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 532 538 <span type="species:ncbi:9913">bovine</span>
Human umbilical vein endothelial cells (HUVECs; Takara) were cultured in EBM-2 (Takara) containing 2% fetal bovine serum and EGMTM-2 SingleQuots (Takara) and used within four passages. Viral titers were determined using an Adeno-XTM rapid titer kit (Clontech). Primary liver sinusoidal endothelial cells were prepared from the livers of wild-type and ST6Gal I-deficient mice using CD146 MicroBeads (Miltenyi Biotec), according to the manufacturer's protocol, cultured in Dulbecco's modified Eagle's medium/F-12 containing 10% fetal bovine serum and 50 mug/ml endothelial mitogen (Biomedical Technologies Inc.), and used within three passages.
###end p 13
###begin title 14
Immunofluorescence
###end title 14
###begin p 15
###xml 785 805 781 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sambucus sieboldiana</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 202 206 <span type="species:ncbi:9925">goat</span>
###xml 559 562 <span type="species:ncbi:10116">rat</span>
###xml 632 637 <span type="species:ncbi:10090">mouse</span>
###xml 710 715 <span type="species:ncbi:9606">human</span>
###xml 785 805 <span type="species:ncbi:45463">Sambucus sieboldiana</span>
###xml 913 919 <span type="species:ncbi:9986">rabbit</span>
Mouse endothelial cells or HUVECs were grown on type I collagen-coated chamber slides (Iwaki). After fixation with 4% paraformaldehyde, treatment with 0.1% Triton X-100 for 15 min, and blocking with 5% goat serum in PBS, the cells were incubated with anti-PECAM (MEC13.3; 1:100 dilution; BD Biosciences) and anti-adaptin gamma (1:100 dilution; BD Transduction Laboratories) or anti-EEA-1 (1:100 dilution; BD Transduction Laboratories) antibodies or an anti-lysobisphosphatidic acid antibody. The cells were then incubated with Alexa Fluor 488-conjugated anti-rat IgG (1:100 dilution; Invitrogen) and Alexa Fluor 546-conjugated anti-mouse IgG (1:100 dilution; Invitrogen), respectively. For the HUVECs, an anti-human PECAM antibody (H-300; 1:100 dilution; Santa Cruz Biotechnology) and Sambucus sieboldiana agglutinin (SSA)-biotin (1:100 dilution; Honen Co.) were used, followed by Alexa Fluor 546-conjugated anti-rabbit IgG (1:100 dilution; Invitrogen) and Alexa Fluor 488-conjugated streptavidin (1:100 dilution; Invitrogen). After washing with PBS, the samples were mounted in ProLong Gold antifade reagent containing 4',6-diamidino-2-phenylindole (Invitrogen) and observed using an FV1000-D laser scanning confocal microscope (Olympus).
###end p 15
###begin title 16
Immunohistochemistry
###end title 16
###begin p 17
###xml 70 71 70 71 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 837 838 830 831 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 862 863 855 856 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 1098 1102 <span type="species:ncbi:9925">goat</span>
###xml 1108 1111 <span type="species:ncbi:10116">rat</span>
###xml 1254 1265 <span type="species:ncbi:3704">horseradish</span>
###xml 1720 1724 <span type="species:ncbi:9925">goat</span>
###xml 1730 1736 <span type="species:ncbi:9986">rabbit</span>
To prepare brain sections, mice were perfused transcardially with 0.1 m phosphate-buffered 4% paraformaldehyde, sequentially immersed in the same fixative for 16 h, phosphate-buffered 20% sucrose for 6 h, and phosphate-buffered 40% sucrose for 16 h at 4 degreesC, and then frozen. Sections (10-mum thickness) were mounted on aminopropyltriethoxysilane-coated glass slides and air-dried for 15 min. For TJA-I lectin staining, we performed fluorescence-indirect tyramide signal amplification. Briefly, brain sections were incubated with 0.3% hydrogen peroxidase in methanol, treated with the blocking solutions supplied in a tyramide signal amplification kit (TSA Biotin System; PerkinElmer Life Sciences), and then incubated with anti-PECAM antibodies MEC13.3 (BD Biosciences) or M-20 (Santa Cruz Biotechnology) diluted 1:500 in TBS (0.1 m Tris-HCl, pH 7.5, 0.15 m NaCl) overnight at 4 degreesC. After three rinses with TNT buffer (TBS containing 0.05% Tween 20) for 5 min each, the sections were incubated with biotinylated TJA-I lectin (1:1000 dilution; Honen Co.) plus Alexa Fluor 546-conjugated goat anti-rat IgG (1:100 dilution; Molecular Probes) for 45 min. After three rinses with TNT buffer, tyramide-enhanced immunoreactivity was visualized with horseradish peroxidase-conjugated streptavidin (1:100 dilution; Invitrogen) for 45 min and Alexa Fluor 488-conjugated tyramide (1:10 dilution; Molecular Probes) for 10 min. When we performed single staining for TJA-I lectin or PECAM, each staining pattern was identical to that obtained in the double staining. To detect ST6Gal I, we performed the tyramide signal amplification method using an anti-ST6Gal I antibody (1:100 dilution; IBL-Japan Co.) and biotinylated goat anti-rabbit IgG (1:100 dilution; GE Healthcare).
###end p 17
###begin title 18
Real Time Quantitative PCR
###end title 18
###begin p 19
###xml 332 334 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 408 410 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 497 499 496 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 543 545 542 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Total RNA was isolated from mouse lung tissues using TRIzol reagent (Invitrogen), and 5-10 mug of the RNA was reverse-transcribed with random hexamers using a SuperScript II reverse transcription kit (Invitrogen) according to the manufacturer's protocol. Amplifications of the cDNA and the PCR conditions were described previously (16). The probes for PECAM were labeled with the fluorescent reporter dye FAMTM. The probes for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were labeled with VICTM at their 5' ends and the quencher dye TAMRATM at their 3' ends. The expression levels of the target gene were measured in duplicate and normalized by the corresponding GAPDH expression levels.
###end p 19
###begin title 20
Western Blotting
###end title 20
###begin p 21
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 571 582 <span type="species:ncbi:3704">Horseradish</span>
###xml 605 611 <span type="species:ncbi:9793">donkey</span>
###xml 617 621 <span type="species:ncbi:9925">goat</span>
###xml 631 636 <span type="species:ncbi:10090">mouse</span>
###xml 945 956 <span type="species:ncbi:3704">horseradish</span>
###xml 979 983 <span type="species:ncbi:9925">goat</span>
###xml 989 994 <span type="species:ncbi:10090">mouse</span>
Lung tissues from mice and HUVEC lysates were homogenized in T-PER Tissue Protein Extraction Reagent (Pierce) containing a protease inhibitor mixture (Roche Applied Science). The lung homogenates (10 mug of protein), HUVEC lysates (10 mug of protein), or immunoprecipitated samples were separated by SDS-PAGE using 4-20% gradient gels and transferred to nitrocellulose membranes. The membranes were incubated with an anti-PECAM antibody (M-20; 1:2000 dilution; Santa Cruz Biotechnology) or an anti-phosphotyrosine antibody (6E10; 1:1000 dilution; Roche Applied Science). Horseradish peroxidase-conjugated donkey anti-goat and anti-mouse IgG (1:1000 dilution; Jackson ImmunoResearch) were used as the secondary antibodies and a SuperSignal chemiluminescent substrate (Thermo Fisher Scientific Inc.) was used for detection. As a loading control, we detected GAPDH on the same membranes using an anti-GAPDH antibody (1:1000 dilution; Chemicon) and horseradish peroxidase-conjugated goat anti-mouse IgG (1:1000 dilution; Amersham Biosciences). The detected bands for PECAM and GAPDH were quantified using a Luminoimage Analyzer LAS-1000 PLUS (Fuji Film).
###end p 21
###begin title 22
Cell-surface Biotinylation
###end title 22
###begin p 23
###xml 196 197 190 191 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Liver sinusoidal endothelial cells grown on 60-mm culture plates were labeled with Sulfo-NHS-LC-Biotin (Pierce; 1 ml/ml ice-cold PBS, pH 8.0) for 30 min at 4 degreesC. After three washes with 0.1 m glycine in PBS, pH 8.0, and one wash with PBS, culture medium was added to the plates, and the cells were cultured for defined periods of time (0, 3, 6, 12, and 24 h).
###end p 23
###begin title 24
Flow Cytometry
###end title 24
###begin p 25
###xml 209 210 209 210 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 363 364 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 300 306 <span type="species:ncbi:9913">bovine</span>
Transfection of endothelial cells was achieved by infection with adenovirus preparations for ST6Gal I or LacZ using equivalent plaque-forming units/cell. 48 h after infection, the cells were detached with 20 mm EDTA in PBS and resuspended as single cell suspensions in FACS buffer (PBS containing 1% bovine serum albumin and 0.05% sodium azide). The cells (5 x 105) were incubated with SSA-fluorescein isothiocyanate (10 mug/ml) or an anti-PECAM-PE antibody (5 mug/ml; Santa Cruz Biotechnology) for 30 min on ice, washed three times, and suspended in FACS buffer. Flow cytometry data were acquired using an EPICS XL cytometer (Beckman Coulter) and analyzed using the Expo32 software (Beckman Coulter).
###end p 25
###begin title 26
Immunoprecipitation and SSA Lectin Precipitation
###end title 26
###begin p 27
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Lung lysates were prepared from wild-type and ST6Gal I-deficient mice. To release the PECAM complexes, the lysates were boiled in the presence of 0.5% SDS and then diluted to 0.1% SDS before immunoprecipitation. The lysates (1 mg/ml) were precleared with protein G-agarose for 30 min. After centrifugation to remove insoluble material, the supernatants (100 mul) were incubated with 2.5 mug of an anti-PECAM antibody (M-20) or 30 mul of SSA-agarose (Honen Co.) for 16 h. For PECAM precipitation, 30 mul of protein G-Sepharose was added. The precipitates were washed four times, separated by SDS-PAGE, transferred to nitrocellulose, and probed with an anti-PECAM antibody (M-20).
###end p 27
###begin title 28
In Vitro PECAM Pulldown Assay
###end title 28
###begin p 29
###xml 20 24 20 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R90A</sub>
###xml 301 316 299 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vibrio cholerae</italic>
###xml 751 752 749 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 301 316 <span type="species:ncbi:666">Vibrio cholerae</span>
###xml 818 823 <span type="species:ncbi:9606">human</span>
Fc-PECAM or Fc-PECAMR90A protein was purified from culture media obtained from COS cells transiently expressing the protein. Fc-PECAM (200 ng) absorbed onto 15 mul of protein A-Sepharose was incubated with His-tagged PECAM (PECAM-His, 1 mug; R&D Systems) in the presence or absence of 2 milliunits of Vibrio cholerae sialidase (Nacalai Tesque) in PBS for 1 h. Alternatively, Fc-PECAM that was incubated with sialidase for 1 h was washed to remove sialidase and then incubated with PECAM-His in PBS for another 1 h. The reaction mixtures were analyzed by Western blotting with an anti-PECAM antibody (M-185; Santa Cruz Biotechnology). After the incubation, the proteins absorbed on the Sepharose beads were analyzed by Western blotting with an anti-His6 antibody (Roche Applied Science) for His-tagged PECAM or an anti-human IgG antibody (Southern Biotech) for Fc-PECAM.
###end p 29
###begin title 30
In Vitro Induction and Quantification of Apoptosis
###end title 30
###begin p 31
###xml 82 83 81 82 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 119 121 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
Confluent mouse endothelial cells grown on 24-well plates were treated with 0.5 mum staurosporine to induce apoptosis (10). At 0, 2, 4, and 8 h after the addition of staurosporine, the cells were measured for their caspase-3/-7 activities using a Caspase-Glo 3/7 assay kit (Promega). Briefly, a luminogenic substrate containing an Asp-Glu-Val-Asp sequence was added and incubated at 37 degreesC for 1 h, followed by analysis using a multiwell luminometer.
###end p 31
###begin title 32
RESULTS
###end title 32
###begin title 33

###end title 33
###begin title 34

###end title 34
###begin title 35
PECAM Expression Is Altered by ST6Gal I Deficiency
###end title 35
###begin p 36
###xml 155 157 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 159 161 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 674 680 659 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 680 681 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 841 847 826 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 847 848 832 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1067 1068 1052 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1173 1175 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1265 1267 1242 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1365 1371 1342 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1371 1372 1348 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1696 1702 1665 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1702 1703 1671 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 2098 2104 2067 2073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 2104 2105 2073 2074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 2292 2298 2261 2267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 2298 2299 2267 2268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 835 839 <span type="species:ncbi:10090">mice</span>
###xml 1209 1213 <span type="species:ncbi:10090">mice</span>
###xml 1359 1363 <span type="species:ncbi:10090">mice</span>
###xml 1609 1613 <span type="species:ncbi:10090">mice</span>
###xml 1690 1694 <span type="species:ncbi:10090">mice</span>
###xml 1938 1942 <span type="species:ncbi:10090">mice</span>
###xml 2092 2096 <span type="species:ncbi:10090">mice</span>
###xml 2185 2189 <span type="species:ncbi:10090">mice</span>
Based on previous reports that endothelial cells express significant levels of alpha2,6-linked sialic acid, which are increased by inflammatory cytokines (15, 17), we tried to elucidate a role for alpha2,6-linked sialic acid in endothelial functions. First, we performed immunohistochemical analyses of brain sections from wild-type and ST6Gal I-deficient mice using an anti-ST6Gal I antibody or TJA-I lectin that recognizes Siaalpha2,6Galbeta1,4GlcNAc residues. In the brain sections from wild-type mice, blood vessels were exclusively detected by TJA-I lectin, because all of the TJA-I positive signals were perfectly matched with those of PECAM as an endothelial marker (Fig. 1A). The specificity of the TJA-I staining was confirmed by the fact that this staining was totally abolished in the brain sections from ST6Gal I-deficient mice (Fig. 1B). Furthermore, we found that ST6Gal I itself was exclusively detected in the blood vessels. Our findings that ST6Gal I products were not present in the brain parenchyma are consistent with a previous report that brain N-glycans predominantly carry alpha2,3-linked sialic acid, with little or no alpha2,6-linked sialic acid (18). Even though ST6Gal I-deficient mice grow normally and exhibit no tissue abnormalities (19), immunostaining of PECAM was also abolished in the brain sections from ST6Gal I-deficient mice (Fig. 1B). We confirmed that PECAM itself contained alpha2,6-linked sialic acid residues added by ST6Gal I, because agarose coupled with the Siaalpha2,6-Gal-binding SSA lectin pulled down almost all of the PECAM in tissue lysates from wild-type mice but was unable to pull down PECAM in tissue lysates from ST6Gal I-deficient mice (Fig. 1C), in which PECAM was modified with other types of sialic acids (). Because the glycosylation-independent anti-PECAM antibody raised against a peptide at the C terminus of PECAM did not stain the brain sections from ST6Gal I-deficient mice (), defective PECAM glycosylation was not related to this result. On the contrary, the levels of PECAM mRNA were almost the same in the two types of mice (Fig. 1D). Furthermore, Western blot analyses of tissue lysates from ST6Gal I-deficient mice revealed that the total level of PECAM was reduced to only about 70% of the normal level in the lung (Fig. 1E).
###end p 36
###begin p 37
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Altered PECAM expression in ST6Gal I-deficient mice.</bold>
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 273 282 269 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yellow. B</italic>
###xml 315 317 311 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 343 345 339 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KO</italic>
###xml 453 463 449 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scale bars</italic>
###xml 474 475 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 677 678 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 943 944 936 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 951 952 944 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1126 1130 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 1204 1205 1194 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1215 1216 1205 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 1035 1039 <span type="species:ncbi:10090">mice</span>
Altered PECAM expression in ST6Gal I-deficient mice.A, brain sections from wild-type mice were stained with the Siaalpha2,6Gal-binding TJA-I lectin and an anti-PECAM antibody (MEC13.3) and then observed by confocal fluorescence microscopy. The colocalized staining appears yellow. B, brain sections from wild-type (WT) and ST6Gal I-deficient (KO) mice were stained with the TJA-I lectin, an anti-ST6Gal I antibody, and an anti-PECAM antibody (MEC13.3). Scale bars, 200 mum. C, lung homogenates prepared from wild-type and ST6Gal I-deficient mice were precipitated with SSA-agarose. The precipitated samples were analyzed by Western blotting with an anti-PECAM antibody (M-20). D, lung PECAM and GAPDH mRNA levels in wild-type and ST6Gal I-deficient mice were analyzed by real time PCR. The expression levels of PECAM were measured in duplicate and normalized by the corresponding GAPDH expression levels. Data are presented as means +/- S.E. (n = 3). E, lung homogenates (10 mug of total protein) from wild-type and ST6Gal I-deficient mice were analyzed by immunoblotting with anti-PECAM (M-20) and anti-GAPDH antibodies. The bars represent the relative PECAM immunoreactivities shown as means +/- S.E. (n = 6). *, p < 0.001.
###end p 37
###begin title 38
ST6Gal I Expression Increases Cell-surface PECAM Residency
###end title 38
###begin p 39
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 448 454 432 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 454 455 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 542 548 526 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 548 549 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 681 687 649 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 689 690 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 695 696 663 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 939 941 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 989 995 953 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 995 996 959 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1458 1464 1422 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1464 1465 1428 1429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1467 1478 1431 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panels</italic>
###xml 1677 1683 1641 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1683 1684 1647 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1686 1698 1650 1662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panels</italic>
###xml 1960 1966 1924 1930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 1966 1967 1930 1931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 2093 2094 2057 2058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 2288 2290 2252 2254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 2292 2294 2256 2258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 2455 2461 2419 2425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 2461 2462 2425 2426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 1297 1301 <span type="species:ncbi:10090">mice</span>
###xml 1452 1456 <span type="species:ncbi:10090">mice</span>
N-Glycan chain multivalency has been proven to enhance the cell-surface residency of growth-modulating receptors (20). Therefore, we examined whether ST6Gal I overexpression in endothelial cells could enhance the level of cell-surface PECAM. Overexpression of ST6Gal I in HUVECs using an adenovirus method for gene delivery resulted in an approximately40% increase in cell-surface alpha2,6-linked sialic acid compared with the control LacZ vector (Fig. 2A). Even though the total PECAM level was not affected by this ST6Gal I overexpression (Fig. 2B), the cell-surface PECAM was increased to approximately140% in response to the increased cell-surface alpha2,6-linked sialic acid (Fig. 2, A and C). In addition, PECAM immunoreactivity was detected in tissue sections from ST6Gal I-deficient mice after autoclave treatment for antigen retrieval (). Because the level of cell-surface VE-cadherin, which contains alpha2,6-linked sialic acid (21), was not affected by ST6Gal I overexpression (Fig. 2C), there appeared to be selectivity for the correlation between ST6Gal I expression and the cell-surface residency of membrane glycoproteins. To explore the intracellular behavior of endothelial PECAM, we isolated liver sinusoidal endothelial cells from the livers of wild-type and ST6Gal I-deficient mice using an established method (). Immunostaining analyses revealed that PECAM was localized at the cell borders in the endothelial cells from wild-type mice (Fig. 3A, left panels). In the ST6Gal I-deficient cells, however, this junctional PECAM localization was absent and instead an increased level of intracellular PECAM was colocalized with the early endosome marker EEA-1 (Fig. 3A, right panels) and the late endosome marker lysobisphosphatidic acid (). These results indicate that more PECAM was endocytosed under ST6Gal I deficiency. After overexpression of ST6Gal I in ST6Gal I-deficient cells, the intracellular PECAM was returned to the cell borders (Fig. 3B). Based on these results, we suspected that the cell-surface half-life of PECAM was decreased, similar to the case for other N-glycan mutations in which the cell-surface expressions of growth factor receptors and glucose transporters are greatly diminished under highly branching GlcNAcT glycosyltransferase deficiency (22, 23). The kinetics of the cell-surface retention of PECAM revealed that the PECAM half-life at the cell surface was decreased by 2-fold in the absence of ST6Gal I (Fig. 3C).
###end p 39
###begin p 40
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Increased cell-surface expression of PECAM after ST6Gal I expression.</bold>
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 163 165 163 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST</italic>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FITC</italic>
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 451 453 451 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST</italic>
###xml 478 482 478 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ</italic>
###xml 566 570 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 656 657 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 664 665 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 857 860 851 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MFI</italic>
Increased cell-surface expression of PECAM after ST6Gal I expression.A, transfection of HUVECs was achieved by infection with adenovirus preparations of ST6Gal I (ST) or LacZ using 50 plaque-forming units/cell. At 48 h after infection, the cells (5 x 105) were detached, resuspended as single-cell suspensions, and probed with SSA-fluorescein isothiocyanate (FITC) or an anti-PECAM-PE antibody. B, lysates of HUVECs infected with ST6Gal I adenovirus (ST) or control adenovirus (LacZ) were analyzed by Western blotting using anti-PECAM and anti-GAPDH antibodies. The bars represent the relative immunoreactivities of PECAM to GAPDH shown as means +/- S.E. (n = 3). C, cell-surface expressions of alpha2,6-sialic acid (detected by SSA-biotin and Alexa Fluor 488-conjugated streptavidin), PECAM, and VE-cadherin are shown as the mean fluorescence intensities (MFI) in HUVECs infected with ST6Gal I adenovirus or control adenovirus.
###end p 40
###begin p 41
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Altered PECAM expression in ST6Gal I-deficient endothelial cells.</bold>
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 141 143 141 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 169 171 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KO</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 285 292 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adaptin</italic>
###xml 294 297 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 328 333 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EEA-1</italic>
###xml 335 338 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 341 350 337 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scale bar</italic>
###xml 360 361 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 492 497 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST-Ad</italic>
###xml 508 515 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LacZ-Ad</italic>
###xml 625 630 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 666 669 661 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 707 711 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DAPI</italic>
###xml 714 718 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">blue</italic>
###xml 721 730 716 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scale bar</italic>
###xml 740 741 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
Altered PECAM expression in ST6Gal I-deficient endothelial cells.A, primary liver sinusoidal endothelial cells were prepared from wild-type (WT) and ST6Gal I-deficient (KO) mice, fixed, and stained with an anti-PECAM antibody (green) and antibodies against a trans-Golgi marker (gamma-adaptin; red) or an early endosome marker (EEA-1; red). Scale bar, 20 mum. B, primary liver sinusoidal endothelial cells from ST6Gal I-deficient mice were infected with adenovirus preparations for ST6Gal I (ST-Ad) or LacZ (LacZ-Ad) using 50 plaque-forming units/cell. 48 h after infection, the cells were fixed and stained with SSA lectin (green), an anti-PECAM antibody (MEC13.3, red), and 4',6-diamidino-2-phenylindole (DAPI) (blue). Scale bar, 20 mum. C, half-lives of PECAM cell-surface expression on endothelial cells from wild-type and ST6Gal I-deficient mice were determined after cell-surface biotinylation and incubation for 3, 6, 12, and 24 h. Data are presented as the means +/- S.E. from three separate experiments.
###end p 41
###begin title 42
ST6Gal I Deficiency Causes Functional Abnormality of PECAM
###end title 42
###begin p 43
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 431 437 431 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 486 492 486 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 836 842 836 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 842 843 842 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 907 908 907 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1023 1024 1023 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1024 1025 1024 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">&#8211;</xref>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1597 1603 1597 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 1603 1604 1603 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 1392 1396 <span type="species:ncbi:10090">mice</span>
Even though the precise mechanism by which PECAM transduces inhibitory signals to the cell remains to be determined, an important step appears to be the tyrosine phosphorylation within the immunoreceptor tyrosine-based inhibitory motif of PECAM, which leads to SHP2 recruitment and translocation to cell junctions (7, 10, 24). In ST6Gal I-deficient mice, the level of tyrosine phosphorylation of PECAM was significantly decreased (Fig. 4A) and fewer PECAM.SHP2 complexes were detected (Fig. 4B), implying that ST6Gal I-dependent cell-surface PECAM localization is required for the formation of PECAM.SHP2 complexes to confer cell signaling to endothelial cells. Indeed, the level of phosphotyrosine in the endothelial cells from ST6Gal I-deficient mice was significantly higher than that in the corresponding cells from wild-type mice (Fig. 4C). Even though PECAM is regarded as a multifunctional molecule (6, 25), several reports have highlighted that PECAM functions as an inhibitor of mitochondrion-dependent apoptosis (8-10). We therefore speculated that ST6Gal I deficiency would increase the sensitivity of endothelial cells to mitochondrion-dependent apoptotic stimuli, because of the lack of functional PECAM. To directly examine whether ST6Gal I-deficient endothelial cells were more sensitive to apoptotic stimuli, we treated endothelial cells from wild-type and ST6Gal I-deficient mice with staurosporine, a trigger for mitochondrion-dependent apoptosis. The ST6Gal-deficient endothelial cells were indeed more sensitive to staurosporine treatment than the wild-type endothelial cells (Fig. 4D).
###end p 43
###begin p 44
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ST6Gal I expression is necessary for PECAM to transduce inhibitory signals.</bold>
###xml 75 76 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 152 154 152 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 180 182 180 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KO</italic>
###xml 273 275 273 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pY</italic>
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 477 479 476 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pY</italic>
###xml 491 492 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 681 685 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">STSP</italic>
###xml 855 856 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 867 873 864 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 899 901 896 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP</italic>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
ST6Gal I expression is necessary for PECAM to transduce inhibitory signals.A and B, PECAM complexes were precipitated from lung lysates from wild-type (WT) and ST6Gal I-deficient (KO) mice using an anti-PECAM antibody and analyzed with anti-PECAM and anti-phosphotyrosine (pY) antibodies (A) or anti-SHP2 antibodies (B). C, endothelial cell lysates (20 mug of protein) from wild-type and ST6Gal I-deficient mice were analyzed by Western blotting using an anti-phosphotyrosine (pY) antibody. D, primary liver sinusoidal endothelial cells from the livers of wild-type and ST6Gal I-deficient mice were grown on 96-well plates. At 0, 2, 4, and 8 h after the addition of staurosporine (STSP), the cells were measured for their caspase-3/-7 activities using a multiwell luminometer. Data are presented as the means +/- S.E. from three separate experiments. **, p < 0.0005, versus ST6Gal I-deficient mice. IP, immunoprecipitated.
###end p 44
###begin title 45
Sialic Acid-dependent Homophilic PECAM Interactions
###end title 45
###begin p 46
###xml 319 321 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 353 354 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 420 421 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 443 445 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 445 446 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">&#8211;</xref>
###xml 446 448 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 570 572 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 572 573 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30 B31">&#8211;</xref>
###xml 573 575 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 696 697 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 699 701 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 808 816 800 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1088 1094 1080 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1096 1097 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1102 1103 1094 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1299 1301 1291 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1342 1346 1334 1338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R90A</sub>
###xml 1489 1493 1481 1485 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R90A</sub>
###xml 1505 1511 1497 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1511 1512 1503 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1748 1754 1740 1746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1756 1757 1748 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1762 1763 1754 1755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
Given that cell-surface retention of PECAM is greatly decreased by ST6Gal I deficiency, it is possible that an alpha2,6-linked sialic acid-binding protein exists at the cell surface. It is generally accepted that the cell-surface residency of glycoproteins is partly supported by galectin, a galactose-binding protein (20). Nevertheless, recognition of N-glycans by galectin was found to be disrupted by modification of N-glycans by ST6Gal I (26-28). A well known alpha2,6-linked sialic acid-recognizing Ig superfamily member, CD22, is restricted to the B-cell lineage (29-32). Because accumulating data support the idea that PECAM homophilic interactions are requisite for its proper functions (8, 33), we speculated that sialic acids would mediate homophilic PECAM interactions. Consequently, we performed in vitro assays using Fc-tagged PECAM (PECAM-Fc) and His-tagged PECAM (PECAM-His). Fc-PECAM immobilized onto protein A-Sepharose was able to pull down PECAM-His, and this interaction was abolished by sialidase treatment of either or both PECAM-Fc and PECAM-His, or only PECAM-Fc (Fig. 5, A and B), thereby providing direct evidence of sialic acid-dependent homophilic PECAM interactions. Because a conserved Arg in the N-terminal Ig domain is essential in sialic acid recognition by Siglec (34), we constructed the PECAM mutant, PECAMR90A, in which highly conserved Arg-90 in the first Ig domain was replaced with Ala. Homophilic interaction of PECAM was markedly lost in the PECAMR90A-Fc mutant (Fig. 5C), indicating that Arg-90 is an interaction site on PECAM. When we stained HUVECs with SSA lectin and an anti-PECAM antibody, both the SSA epitopes and PECAM were more concentrated at cell-cell junctions than in the peripheral regions (Fig. 5, D and E), further suggesting a role for alpha2,6-sialic acid in the PECAM interactions.
###end p 46
###begin p 47
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sialic acid-based homophilic PECAM interactions.</bold>
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 230 241 230 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V. cholerae</italic>
###xml 442 450 442 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PECAM-Fc</italic>
###xml 478 487 478 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PECAM-His</italic>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 509 511 509 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WT</italic>
###xml 521 525 521 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R90A</sub>
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R90A</italic>
###xml 650 651 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 725 734 725 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scale bar</italic>
###xml 744 745 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 890 894 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 973 974 972 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">j</italic>
###xml 992 993 991 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1026 1027 1023 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1037 1038 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1052 1053 1049 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1062 1066 1059 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DAPI</italic>
###xml 230 241 <span type="species:ncbi:666">V. cholerae</span>
###xml 418 423 <span type="species:ncbi:9606">human</span>
Sialic acid-based homophilic PECAM interactions.A, purities of PECAM-Fc and PECAM-His were verified by silver staining. B, PECAM-Fc absorbed to protein A-Sepharose was incubated with His-tagged PECAM in the presence or absence of V. cholerae sialidase. Alternatively, sialidase-treated PECAM-Fc was incubated with PECAM-His. The absorbed proteins on the protein A-Sepharose were analyzed by Western blotting with anti-human IgG antibody (for PECAM-Fc) or anti-His antibody (for PECAM-His). C, after PECAM-Fc (WT) or PECAMR90A-Fc (R90A) was incubated with PECAM-His, the absorbed proteins on the protein A-Sepharose were analyzed by Western blotting. D, HUVECs were stained with SSA lectin and an anti-PECAM antibody (H-200). Scale bar, 20 mum. E, fluorescence intensity profiles were taken along the line shown in the image of HUVECs stained with SSA lectin and an anti-PECAM antibody. The bars represent the signal intensities of the PECAM and SSA epitopes at junctional (j) and peripheral (p) areas shown as means +/- S.E. (n = 6). *, p < 0.005; **, p < 0.05. DAPI, 4,6-diamidino-2-phenylindole.
###end p 47
###begin title 48
DISCUSSION
###end title 48
###begin p 49
###xml 110 116 110 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 867 869 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
Based on our present findings, a model for sialic acid-dependent homophilic PECAM interactions was developed (Fig. 6). PECAM with normal sialic acids mediates homophilic interactions at the cell surface to recruit SHP2 phosphatase to transduce inhibitory signals, such as antiapoptotic signals, to the cell. Under ST6Gal I deficiency, PECAM fails to mediate homophilic interactions, thus leading to an inability to transduce signals to the cell. As an underlying mechanism of the sialic acid-based homophilic PECAM interactions, we speculated that PECAM itself would be an alpha2,6-linked sialic acid-binding protein because PECAM also belongs to the Ig superfamily that includes a subfamily of sialic acid-binding Ig-like lectins (Siglecs). Even though PECAM is not likely to possess an N-terminal V-set Ig domain that plays a role in sialic acid binding in Siglec (34), replacement of conserved Arg-90 in the first Ig domain of PECAM with Ala greatly reduced the homophilic binding activity, indicating that Arg-90 is an interaction site of PECAM. A detailed molecular structural study to elucidate how and which part of PECAM exhibits its sialic acid-binding activity is a challenging issue for the future.
###end p 49
###begin p 50
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schematic diagrams of a model for sialic acid-dependent homophilic PECAM interactions.</bold>
###xml 251 255 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left</italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right</italic>
###xml 392 394 392 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</italic>
Schematic diagrams of a model for sialic acid-dependent homophilic PECAM interactions. PECAM proteins modified with sialic acids interact with one another at the cell surface, and subsequently recruit SHP2 to transduce inhibitory signals to the cell (left). Without the sialic acids, PECAM fails to mediate the homophilic interactions required for the underlying signal transduction (right). TM, transmembrane.
###end p 50
###begin p 51
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">&#8211;</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
Endothelial cells from ST6Gal I-deficient mice show an overlapping phenotype with the corresponding cells from PECAM-deficient mice, in terms of their increased sensitivity to mitochondrion-dependent apoptotic stimuli (8-10). Interestingly, stressed conditions enhance the endothelial cell-surface expression of PECAM without changing the level of PECAM mRNA, thereby leading to enhanced cell survival signals (12). Glycan modification of PECAM may be responsible for regulating various pathological situations. Nevertheless, because ST6Gal I acts on various endothelial glycoproteins, the identification of key molecules other than PECAM whose functions are regulated by ST6Gal I remains one of our ongoing projects. Finally, our findings that ST6Gal I-deficient endothelial cells exhibit increased sensitivity to apoptotic signals provide new possibilities for the development of glycan-targeted antiangiogenesis strategies.
###end p 51
###begin title 52
Supplementary Material
###end title 52
###begin title 53
Supplemental Data
###end title 53
###begin p 54
This work was supported, in whole or in part, by National Institutes of Health Grant HL57345 (to J. M.). This work was also supported by grants from the Systems Glycobiology Research Project (to N. T.), the Chemical Genomics Research Project from RIKEN (to S. Kojima), Japan Foundation for Applied Enzymology (to S. Kitazume), Yamada Science Foundation (to S. Kitazume), and Grant 18570141 from the Ministry of Education, Science, Sports and Culture of Japan (to S. Kitazume).
###end p 54
###begin p 55
The on-line version of this article (available at ) contains .
###end p 55
###begin p 56
###xml 28 39 28 39 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">VE-cadherin</term>
###xml 39 68 39 68 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="57">vascular endothelial cadherin</p>
###xml 39 68 39 68 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="57">vascular endothelial cadherin</p></def>
###xml 28 68 28 68 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">VE-cadherin</term><def><p textid="57">vascular endothelial cadherin</p></def></def-item>
###xml 68 70 68 70 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">Fc</term>
###xml 70 102 70 102 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="58">hinge and constant region of IgG</p>
###xml 70 102 70 102 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="58">hinge and constant region of IgG</p></def>
###xml 68 102 68 102 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">Fc</term><def><p textid="58">hinge and constant region of IgG</p></def></def-item>
###xml 102 107 102 107 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">GAPDH</term>
###xml 107 147 107 147 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59">glyceraldehyde-3-phosphate dehydrogenase</p>
###xml 107 147 107 147 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="59">glyceraldehyde-3-phosphate dehydrogenase</p></def>
###xml 102 147 102 147 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">GAPDH</term><def><p textid="59">glyceraldehyde-3-phosphate dehydrogenase</p></def></def-item>
###xml 147 152 147 152 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">HUVEC</term>
###xml 152 189 152 189 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="60">human umbilical vein endothelial cell</p>
###xml 152 189 152 189 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="60">human umbilical vein endothelial cell</p></def>
###xml 147 189 147 189 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">HUVEC</term><def><p textid="60">human umbilical vein endothelial cell</p></def></def-item>
###xml 189 194 189 194 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">PECAM</term>
###xml 194 237 194 237 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="61">platelet endothelial cell adhesion molecule</p>
###xml 194 237 194 237 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="61">platelet endothelial cell adhesion molecule</p></def>
###xml 189 237 189 237 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">PECAM</term><def><p textid="61">platelet endothelial cell adhesion molecule</p></def></def-item>
###xml 237 241 237 241 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">SHP2</term>
###xml 241 304 241 304 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="62">Src homology 2 domain-containing protein-tyrosine phosphatase 2</p>
###xml 241 304 241 304 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="62">Src homology 2 domain-containing protein-tyrosine phosphatase 2</p></def>
###xml 237 304 237 304 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">SHP2</term><def><p textid="62">Src homology 2 domain-containing protein-tyrosine phosphatase 2</p></def></def-item>
###xml 304 307 304 307 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">SSA</term>
###xml 307 321 307 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. sieboldiana</italic>
###xml 307 332 307 332 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="63"><italic>S. sieboldiana</italic> agglutinin</p>
###xml 307 332 307 332 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="63"><italic>S. sieboldiana</italic> agglutinin</p></def>
###xml 304 332 304 332 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">SSA</term><def><p textid="63"><italic>S. sieboldiana</italic> agglutinin</p></def></def-item>
###xml 332 340 332 340 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">ST6Gal I</term>
###xml 340 383 340 376 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="64">&#946;-galactoside &#945;2,6-sialyltransferase</p>
###xml 340 383 340 376 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="64">&#946;-galactoside &#945;2,6-sialyltransferase</p></def>
###xml 332 383 332 376 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">ST6Gal I</term><def><p textid="64">&#946;-galactoside &#945;2,6-sialyltransferase</p></def></def-item>
###xml 383 386 376 379 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">PBS</term>
###xml 386 412 379 405 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="65">phosphate-buffered saline.</p>
###xml 386 412 379 405 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="65">phosphate-buffered saline.</p></def>
###xml 383 412 376 405 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">PBS</term><def><p textid="65">phosphate-buffered saline.</p></def></def-item>
###xml 28 412 28 405 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">VE-cadherin</term><def><p textid="57">vascular endothelial cadherin</p></def></def-item><def-item><term id="G2">Fc</term><def><p textid="58">hinge and constant region of IgG</p></def></def-item><def-item><term id="G3">GAPDH</term><def><p textid="59">glyceraldehyde-3-phosphate dehydrogenase</p></def></def-item><def-item><term id="G4">HUVEC</term><def><p textid="60">human umbilical vein endothelial cell</p></def></def-item><def-item><term id="G5">PECAM</term><def><p textid="61">platelet endothelial cell adhesion molecule</p></def></def-item><def-item><term id="G6">SHP2</term><def><p textid="62">Src homology 2 domain-containing protein-tyrosine phosphatase 2</p></def></def-item><def-item><term id="G7">SSA</term><def><p textid="63"><italic>S. sieboldiana</italic> agglutinin</p></def></def-item><def-item><term id="G8">ST6Gal I</term><def><p textid="64">&#946;-galactoside &#945;2,6-sialyltransferase</p></def></def-item><def-item><term id="G9">PBS</term><def><p textid="65">phosphate-buffered saline.</p></def></def-item></def-list>
The abbreviations used are: VE-cadherinvascular endothelial cadherinFchinge and constant region of IgGGAPDHglyceraldehyde-3-phosphate dehydrogenaseHUVEChuman umbilical vein endothelial cellPECAMplatelet endothelial cell adhesion moleculeSHP2Src homology 2 domain-containing protein-tyrosine phosphatase 2SSAS. sieboldiana agglutininST6Gal Ibeta-galactoside alpha2,6-sialyltransferasePBSphosphate-buffered saline.
###end p 56
###begin p 57
vascular endothelial cadherin
###end p 57
###begin p 58
hinge and constant region of IgG
###end p 58
###begin p 59
glyceraldehyde-3-phosphate dehydrogenase
###end p 59
###begin p 60
###xml 0 5 <span type="species:ncbi:9606">human</span>
human umbilical vein endothelial cell
###end p 60
###begin p 61
platelet endothelial cell adhesion molecule
###end p 61
###begin p 62
Src homology 2 domain-containing protein-tyrosine phosphatase 2
###end p 62
###begin p 63
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. sieboldiana</italic>
###xml 0 14 <span type="species:ncbi:45463">S. sieboldiana</span>
S. sieboldiana agglutinin
###end p 63
###begin p 64
beta-galactoside alpha2,6-sialyltransferase
###end p 64
###begin p 65
phosphate-buffered saline.
###end p 65
###begin title 66
Acknowledgments
###end title 66
###begin p 67
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
We thank Dr. Jing Sun (University of Pennsylvania School of Medicine, Philadelphia) for the mouse PECAM pcDNA, Dr. Toshihide Kobayashi (RIKEN ASI) for the anti-lysobisphosphatidic acid antibody, and Dr. Yoshihiro Yoshihara (RIKEN BSI Institute) for pEF-Fc.
###end p 67
###begin title 68
REFERENCES
###end title 68

